Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 97867-33-9
2. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Compound With 2-hydroxypropanoic Acid (1:1)
3. Ciproxin
4. Flociprin
5. Ciprofloxacin (lactate)
6. Uey6xfc224
7. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic Acid;2-hydroxypropanoic Acid
8. Flunase [inj.]
9. 96186-80-0
10. Cipobacter
11. 857213-31-1
12. Ificipro
13. Ciproxin [inj.]
14. Quintor Eye Drops
15. Ciproflox [inj.]
16. Ciproxina [inj.]
17. Flociprin [inj.]
18. 3-quinolinecarboxylic Acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, Mono(2-hydroxypropanoate)
19. Ciprobid Eye Drops
20. Unii-uey6xfc224
21. Ciproxin (tn)
22. Ciprofloxacin Lactat
23. Schembl667608
24. Chembl1077975
25. Dtxsid20913608
26. Ciprofloxacin (as Lactate)
27. (+/-)-ciprofloxacin Lactate
28. Mfcd01759747
29. Ciprofloxacin Lactate [mart.]
30. Akos015896304
31. Ciprofloxacin Lactate [who-dd]
32. Cs-w021038
33. Hy-w040298
34. Ciprofloxacin Lactate, (+/-)-
35. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic Acid; 2-hydroxypropanoic Acid
36. Ds-11431
37. Db-057689
38. Ft-0602944
39. D07702
40. D82460
41. 213c311
42. A845757
43. Q27291047
44. 1-cyclopropyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-quinoline-3-carboxylic Acid; 2-oxidanylpropanoic Acid
45. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Mono(2-hydroxypropanoate)
46. 1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid; 2-hydroxypropanoic Acid
47. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid 2-hydroxypropanoic Acid Salt
48. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid--2-hydroxypropanoic Acid (1/1)
49. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacidcompoundwith2-hydroxypropanoicacid(1:1)
50. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic Acid,2-hydroxypropanoic Acid
51. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, 2-hydroxypropanoate (1:1)
| Molecular Weight | 421.4 g/mol |
|---|---|
| Molecular Formula | C20H24FN3O6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 4 |
| Exact Mass | 421.16491366 g/mol |
| Monoisotopic Mass | 421.16491366 g/mol |
| Topological Polar Surface Area | 130 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 631 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Ciprofloxacin Lactate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ciprofloxacin Lactate, including repackagers and relabelers. The FDA regulates Ciprofloxacin Lactate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ciprofloxacin Lactate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ciprofloxacin Lactate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ciprofloxacin Lactate supplier is an individual or a company that provides Ciprofloxacin Lactate active pharmaceutical ingredient (API) or Ciprofloxacin Lactate finished formulations upon request. The Ciprofloxacin Lactate suppliers may include Ciprofloxacin Lactate API manufacturers, exporters, distributors and traders.
click here to find a list of Ciprofloxacin Lactate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ciprofloxacin Lactate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ciprofloxacin Lactate active pharmaceutical ingredient (API) in detail. Different forms of Ciprofloxacin Lactate DMFs exist exist since differing nations have different regulations, such as Ciprofloxacin Lactate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ciprofloxacin Lactate DMF submitted to regulatory agencies in the US is known as a USDMF. Ciprofloxacin Lactate USDMF includes data on Ciprofloxacin Lactate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ciprofloxacin Lactate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ciprofloxacin Lactate suppliers with USDMF on PharmaCompass.
Ciprofloxacin Lactate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ciprofloxacin Lactate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ciprofloxacin Lactate GMP manufacturer or Ciprofloxacin Lactate GMP API supplier for your needs.
A Ciprofloxacin Lactate CoA (Certificate of Analysis) is a formal document that attests to Ciprofloxacin Lactate's compliance with Ciprofloxacin Lactate specifications and serves as a tool for batch-level quality control.
Ciprofloxacin Lactate CoA mostly includes findings from lab analyses of a specific batch. For each Ciprofloxacin Lactate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ciprofloxacin Lactate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ciprofloxacin Lactate EP), Ciprofloxacin Lactate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ciprofloxacin Lactate USP).
LOOKING FOR A SUPPLIER?
